Urinary tract infections (UTIs) are among the most common infectious diseases worldwide
but are significantly understudied. Uropathogenic E. coli (UPEC) accounts for a significant …

Bio‐hybrid technologies aim to replicate the unique capabilities of biological systems that
could surpass advanced artificial technologies. Soft bio‐hybrid robots consist of synthetic …

In the past few years, microfluidic-based technology has developed microscale models
recapitulating key physical and biological cues typical of the native myocardium. However …

Ischemic heart disease remains one of the most prominent causes of mortalities worldwide
with heart transplantation being the gold-standard treatment option. However, due to the …

The evolution of micro and nanofabrication approaches significantly spurred the
advancements of cardiac tissue engineering over the last decades. Engineering in the micro …

Convergence of life sciences, engineering, and basic sciences has opened new horizons for
biologically inspired innovations, and a considerable number of organ‐on‐a‐chip platforms …

In the last few decades, many pathogenic or likely pathogenic genetic mutations in over
hundred different genes have been described for non-ischemic, genetic cardiomyopathies …

Heart diseases are one of the main causes of death around the world. The great challenge
for scientists is to develop new therapeutic methods for these types of ailments. Stem cells …

Direct detection and analysis of biomolecules and cells in physiological microenvironment is
urgently needed for fast evaluation of biology and pharmacy. The past several years have …

Organs-on-chip technology has recently emerged as a promising tool to generate advanced
cardiac tissue in vitro models, by recapitulating key physiological cues of the native …